Earnest Partners LLC Decreases Holdings in Core Laboratories Inc. $CLB

Earnest Partners LLC cut its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 1.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,630,279 shares of the oil and gas company’s stock after selling 54,441 shares during the period. Earnest Partners LLC owned about 7.74% of Core Laboratories worth $54,418,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CLB. AlphaQuest LLC raised its stake in Core Laboratories by 265,800.0% during the 1st quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company’s stock valued at $40,000 after buying an additional 2,658 shares during the last quarter. Assetmark Inc. raised its stake in Core Laboratories by 92.5% during the 1st quarter. Assetmark Inc. now owns 2,887 shares of the oil and gas company’s stock valued at $43,000 after buying an additional 1,387 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock valued at $57,000 after buying an additional 2,936 shares during the last quarter. BNP Paribas Financial Markets bought a new position in Core Laboratories in the fourth quarter worth approximately $123,000. Finally, XTX Topco Ltd purchased a new position in shares of Core Laboratories during the 1st quarter worth $155,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Trading Up 0.3%

Shares of Core Laboratories stock opened at $11.16 on Thursday. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $21.83. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.70 and a current ratio of 2.27. The company has a market capitalization of $523.15 million, a P/E ratio of 18.00, a P/E/G ratio of 3.36 and a beta of 1.41. The company has a fifty day moving average of $11.49 and a 200 day moving average of $12.67.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, July 23rd. The oil and gas company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.01. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The business had revenue of $130.16 million for the quarter, compared to analysts’ expectations of $129.19 million. During the same period last year, the firm earned $0.22 earnings per share. The business’s quarterly revenue was down .3% on a year-over-year basis. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. On average, sell-side analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 25th. Investors of record on Monday, August 4th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, August 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. Core Laboratories’s payout ratio is currently 6.45%.

Wall Street Analyst Weigh In

Several research firms have recently commented on CLB. Stifel Nicolaus reduced their price objective on Core Laboratories from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Zacks Research raised Core Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, August 15th. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Finally, Citigroup decreased their price objective on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 13th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.50.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.